Mechanism of Action | Sildenafil is a phosphodiesterase enzyme (PDE5) inhibitor. This enzyme is responsible for the degradation cyclic guanosine monophosphate (cGMP) produced in reaction to sexual stimulation. The more cGMP is available, the more durable the erection. Sildenafil inhibits the PDE5 enzyme, preserving cGMP levels, therefore aiding erection viability and durability Erection of the penis is caused by the filling of the penis with blood. Filling occurs because the blood vessels that bring blood to the penis increase in size and deliver more blood to the penis and at the same time, the blood vessels that take blood away from the penis decrease in size and remove less blood from the penis. Sexual stimulation that leads to an erection causes the production and release of nitric oxide in the corpora cavernosa of the penis. The nitric oxide causes an enzyme guanylate cyclase, to produce cyclic guanosine monophosphate (cGMP). It is the cGMP that is primarily responsible for increasing and decreasing the size of the blood vessels carrying blood to and from the penis, respectively, and causing the erection. When the cGMP is destroyed by enzyme phosphodiesterase-5, the blood vessels return to their normal size, blood leaves the penis, and the erection ends. Sildenafil prevents phosphodiesterase-5 from destroying cGMP so that cGMP stays around longer. The persistence of cGMP leads to a more prolonged engorgement of the penis with blood. It relaxes muscles and increases blood flow to particular areas of the body. |
PharmacoKinetics | Absorption: It is readily absorbed from the bloodstream and the bioavailability is about 40%. Distribution: It is widely distributed in protein bound form (96% bound to plasma protein) mostly to tissues. Metabolism: It is metabolized in the liver by an enzyme known as CYP3A4 and others to produce active N-Desmethyl derivatives. Excretion: It is primarily excreted in the feces (80%) and small amount in the urine; |
Onset of action | Within 30 minutes |
Half Life | 4 hours |
Duration of action | 4 hours |
Adverse Effects | 1. Facial flushing 2. Headaches 3. Stomach upset 4. Diarrhea 5. Flu-like symptoms 6. Nausea 7. Back pain 8. Muscle aches 9. Low blood pressure 10. Blurred vision 11. Abnormal ejaculation 12. Prolonged erections 13. Sweating 14. General ill feeling 15. Irregular heartbeat 16. Swelling in hands, ankles, or feet 17. Shortness of breath 18. Lightheadedness 19. Fainting In pre-existing heart disease: 1. Chest pain 2. Heart attacks 3. Death 4. Strokes 5. Palpitations and increased heart rate 6. Vision changes |
Contraindications | 1. Hypersensitivity to Sildenafil 2. Patients on nitrate therapy 3. Patients taking a adrenergic receptor antagonist |
Special Precautions | 1. Do not take Sildenafil more than once a day 2. Contact doctor if erection is painful or lasts longer than 4 hours 3. Heart disease 4. Recent history a heart attack (within the past 90 days) 5. Recent history of stroke or congestive heart failure (within the past 6 months) 6. Angina 7. Hypotension 8. Hypertension 9. Liver disease 10. Kidney disease 11. Sickle cell anemia 12. Multiple myeloma 13. Leukemia 14. Haemophilia 15. Stomach ulcer 16. Retinitis pigmentosa 17. Peyronie`s disease (physical deformity of the penis) 18. Diabetes 19. High cholesterol 20. Pre-existing eye problems 21. One who smoke or are over 50 years old |
Pregnancy | Contraindicated |
Breastfeeding | Contraindicated |
Old Age | Use with caution |
Children | Contraindicated NEONATES: Contraindicated |
Drug Interactions | Non-specific beta-blockers, loop and potassium-sparing diuretics enhance efficacy of sildenafil. Concomitant administration of sildenafil 100mg and amlodipine 5 or 10mg in hypertensive patients led to a mean additional blood pressure reduction of 8mm Hg systolic and 7mm Hg diastolic. Cytochrome P450 inhibitors like erythromycin, ketoconazole, itraconazole are likely to reduce sildenafil clearance. |
Indications | 1. Erectile dysfunction |
Dosage | Adult: 50 mg taken, 1 hour before sexual activity or anywhere from 0.5 – 4 hours before sexual activity. Based on effectiveness and toleration, the dose may be increased to a maximum 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. |
Schedule | H |
Storage | Store at room temperature between 15 - 30°C. Protect from moisture and heat. Keep out of the reach of children. |
Overdose | No overdose, if any overdose occurs then seeks immediate medical attention. Give supportive measures and symptomatic treatment. |
No customer reviews for the moment.
It is a drug used for certain breast, lung and other cancers. Gefitinib is the first selective inhibitor of epidermal growth factor receptor’s (EGFR) tyrosine kinase domain. Thus Gefitinib is an EGFR inhibitor. The target protein (EGFR) is a family of receptors which includes Her 1(erb-B1), Her 2(erb-B2), and Her 3(erb-B3). EGFR is over expressed in the...
IMACY-100mgTyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues. Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
IMACY-400mg n Tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues.Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
BORTENAT2MG INGREDIENT-Bortenat injection contain BortezomibINTRODUCTION-Bortenat 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
CYNIVE-3(Ivermectin USP 3 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-6(Ivermectin USP 6 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-12(Ivermectin USP 12 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
FAVIPIRAVIR - 200 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 400 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 800 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
MOLNUPIRAVIR - 200 mgMolnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing copying errors during viral RNA...
Pharmacology of Drug: Tenofovir Alafenamide (25mg)
Pirfenidone, a prescription medication, treats idiopathic pulmonary fibrosis by reducing lung scarring and swelling, improving breathing. Take it with food at the same time daily. Common side effects include insomnia, headache, dizziness, nausea, and photosensitivity. Inform your doctor about liver or kidney disease and other medications you’re taking. If...